الرئيسية › قصور القلب › تكساس › Houston
التجارب السريرية لـ قصور القلب في Houston، TX
36 دراسات لـ قصور القلب تبحث عن مشاركين في مواقع داخل وحول Houston (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
جارٍ التسجيلالمرحلة 3
- Research Site, Houston
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
جارٍ التسجيلالمرحلة 3
- The Methodist Hospital Research Institute, Houston
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
جارٍ التسجيلالمرحلة 2
- East Texas Cardiology PA, Houston
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
جارٍ التسجيلالمرحلة 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Humble · على بُعد 17 ميل
BiVACOR® Total Artificial Heart Early Feasibility Study
جارٍ التسجيل
- Texas Heart Institute / Baylor St. Luke's Medical Center, Houston
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
جارٍ التسجيلالمرحلة 3
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
A Study of LY3971297 in Participants With Heart Failure
جارٍ التسجيلالمرحلة 1
- Houston Methodist Hospital, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
جارٍ التسجيلالمرحلة 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- و 3 أخرى
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
جارٍ التسجيلالمرحلة 3
- Research Site, Houston
- Research Site, Houston
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
جارٍ التسجيلالمرحلة 3
- CON-10085, Houston, TX, Houston
- Houston, TX Investigative Site CON-10320, Houston
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
جارٍ التسجيلدراسة رصدية
- Methodist DeBakey Heart and Vascular Center, Houston
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
جارٍ التسجيلالمرحلة 3
- Houston, TX Investigative Site 10085, Houston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
جارٍ التسجيل
- Houston Methodist Hospital, Houston
- Memorial Hermann-Texas Medical Center, Houston
- Texas Heart Institute at Baylor St. Luke's Medical Center, Houston
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
جارٍ التسجيلالمرحلة 2
- Local Institution - 151, Houston
- Local Institution - 157, Houston
- Local Institution - 163, Houston
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
جارٍ التسجيلالمرحلة 2/3
- Texas Children's Hospital ( Site 0039), Houston
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
جارٍ التسجيلالمرحلة 2
- Center for Advanced Heart Failure, Houston
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
جارٍ التسجيلدراسة رصدية
- Texas Children's Hospital, Houston
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
جارٍ التسجيل
- Texas Heart Institute, Houston
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
جارٍ التسجيلدراسة رصدية
- Houston, Houston
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
جارٍ التسجيلدراسة رصدية
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- BI Research Center, Houston
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
جارٍ التسجيلالمرحلة 3
- Tenax Investigational Site, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
جارٍ التسجيلالمرحلة 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- و 1 أخرى
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
جارٍ التسجيل
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Assessment of CCM in HF With Higher Ejection Fraction
جارٍ التسجيل
- Baylor College of Medicine, Houston
- Houston Methodist, Houston
- Memorial Hermann Texas Medical Center, Houston
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
جارٍ التسجيلالمرحلة 3
- FIN-10085, Houston, TX, Houston
18F-mFBG Imaging for Myocardial Sympathetic Innervation
جارٍ التسجيلالمرحلة 2
- UT Health Houston, Houston
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
جارٍ التسجيلالمرحلة 3
- Texas Children's Hospital - Cardiology, Houston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
جارٍ التسجيل
- Baylor/Texas Heart, Houston
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
جارٍ التسجيلالمرحلة 3
- Texas Children's Hospital - Cardiology, Houston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
جارٍ التسجيل
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- Houston Methodist, Houston
- UTHealth Memorial Hermann, Houston
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
جارٍ التسجيلدراسة رصدية
- Baylor College of Medicine, Houston
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
جارٍ التسجيل
- Houston Healthcare Medical Center, Houston
Left vs Left Randomized Clinical Trial
جارٍ التسجيل
- Baylor College of Medicine, Houston
Cardiogenic Shock Working Group Registry
جارٍ التسجيلدراسة رصدية
- Houston Methodist Hospital, Houston
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
جارٍ التسجيلالمرحلة 1
- Texas Heart Institute, Houston
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
جارٍ التسجيلدراسة رصدية
- Houston Methodist DeBakey Heart and Vascular Center, Houston
تجارب قصور القلب في مدن أخرى
- New York City, NY51 دراسات
- Boston, MA44 دراسات
- Dallas, TX42 دراسات
- Cleveland, OH33 دراسات
- Chicago, IL31 دراسات
- Philadelphia, PA31 دراسات
- San Francisco, CA29 دراسات
- St. Louis, MO26 دراسات
- Durham, NC26 دراسات
- Kansas City, MO25 دراسات
- Atlanta, GA25 دراسات
- Baltimore, MD24 دراسات
دراسات أخرى في Houston
- سرطان الرئة غير صغير الخلايا145 دراسات
- سرطان الثدي126 دراسات
- السرطان (جميع الأنواع)121 دراسات
- السرطان النقيلي104 دراسات
- سرطان القولون والمستقيم102 دراسات
- سرطان المبيض89 دراسات
- ابيضاض الدم النقوي الحاد85 دراسات
- سرطان الرئة78 دراسات
- سرطان البروستاتا76 دراسات
- سرطان بطانة الرحم68 دراسات
- سرطان البنكرياس61 دراسات
- ميلانوما59 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 05/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.